Liquid Biopsy in Early Screening of Cancers: Emerging Technologies and New Prospects
Liquid biopsy is moving beyond mutation-centric assays to multimodal frameworks that integrate cell-free DNA (cfDNA) signals with additional analytes such as circulating tumor cells (CTCs) and extracellular vesicles (EVs). In this review, we summarize emerging technologies across analytes for early...
Guardado en:
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
MDPI AG
2026-01-01
|
| Colección: | Biomedicines |
| Materias: | |
| Acceso en línea: | https://www.mdpi.com/2227-9059/14/1/158 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|